HAP Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

HAP Trading’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-879,642	Closed	-$11M	–	1291
2014 Q4	$10.8M	Buy	879,642 +290,485	+49%	+$3.55M	0.4%	59
2014 Q3	$5.88M	Buy	589,157 +101,569	+21%	+$943K	0.23%	83
2014 Q2	$3.69M	Buy	487,588 +224,815	+86%	+$897K	0.14%	133
2014 Q1	$865K	Sell	262,773 -4,533	-2%	-$15.9K	0.04%	351
2013 Q4	$887K	Sell	267,306 -180,427	-40%	-$524K	0.03%	465
2013 Q3	$1.35M	Buy	447,733 +365,982	+448%	+$2.51M	0.04%	305
2013 Q2	$669K	Buy	+81,751	New	+$624K	0.02%	448

HAP Trading's ACHN Position: Q1 2015 in Review

HAP Trading sold out of Achillion Pharmaceuticals (ACHN) in Q1 2015, closing a stake of 879,642 shares — an estimated $11M sold.

HAP Trading first reported a position in ACHN in Q2 2013 and held it in 7 quarters. The position peaked at $10.8M in Q4 2014. 173 funds tracked by Wall St. Rank hold ACHN as of Q1 2015.

HAP Trading reported no remaining Achillion Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
HAP Trading sold 879,642 Achillion Pharmaceuticals shares in Q1 2015, an estimated $11M.
HAP Trading first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 7 quarters.
HAP Trading's Achillion Pharmaceuticals position peaked at $10.8M in Q4 2014.
173 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2015.

Based on HAP Trading's 13F filing for Q1 2015, filed 13 May 2015.